{"id":"https://openalex.org/W7167235682","doi":"https://doi.org/10.62917/26.71.1071","title":"ANIFROLUMAB EN DERMATOMIOSITIS JUVENIL AMIOP\u00c1TICA REFRACTARIA: EFICACIA Y SEGURIDAD TRAS INFECCI\u00d3N HERP\u00c9TICA DURANTE TRATAMIENTO CON TOFACITINIB","display_name":"ANIFROLUMAB EN DERMATOMIOSITIS JUVENIL AMIOP\u00c1TICA REFRACTARIA: EFICACIA Y SEGURIDAD TRAS INFECCI\u00d3N HERP\u00c9TICA DURANTE TRATAMIENTO CON TOFACITINIB","publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W7167235682","doi":"https://doi.org/10.62917/26.71.1071"},"language":"es","primary_location":{"id":"doi:10.62917/26.71.1071","doi":"https://doi.org/10.62917/26.71.1071","is_oa":false,"landing_page_url":"https://doi.org/10.62917/26.71.1071","pdf_url":null,"source":{"id":"https://openalex.org/S7407089388","display_name":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Libro de comunicaciones 71 Congreso SEFH","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109744730","display_name":"JAVIER FRA Y\u00c1\u00d1EZ","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Fra Y\u00e1\u00f1ez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140006151","display_name":"Esther Salgueiro V\u00e1zquez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther Salgueiro V\u00e1zquez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080787107","display_name":"Constanza G\u00f3mez de O\u00f1a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Constanza G\u00f3mez de O\u00f1a","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060737108","display_name":"Leticia G\u00f3mez de Segura Iriarte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leticia G\u00f3mez de Segura Iriarte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048305784","display_name":"Mar\u00eda Dolores Colunga Arg\u00fcelles","orcid":"https://orcid.org/0000-0003-4824-1244","observed_orcids":["https://orcid.org/0000-0003-4824-1244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mar\u00eda Dolores Colunga Arg\u00fcelles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100495915","display_name":"SILVIA MAR\u00cdA SANZ RODR\u00cdGUEZ","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Mar\u00eda Sanz Rodr\u00edguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.8964999914169312,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.8964999914169312,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.05829999968409538,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anifrolumab","display_name":"anifrolumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/juvenile-dermatomyositis","display_name":"juvenile dermatomyositis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/amyopathic-dermatomyositis","display_name":"amyopathic dermatomyositis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/refractory-dermatomyositis","display_name":"refractory dermatomyositis","score":0.9070000052452087},{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/herpesvirus-infection","display_name":"herpesvirus infection","score":0.8529999852180481},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7329999804496765},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.6000000238418579},{"id":"https://openalex.org/keywords/il-4-receptor-antagonist","display_name":"IL-4 receptor antagonist","score":0.527999997138977},{"id":"https://openalex.org/keywords/il-13-receptor-antagonist","display_name":"IL-13 receptor antagonist","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8779000043869019},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3253999948501587},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.3239000141620636},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2574000060558319},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.2483000010251999},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2329999953508377},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.2134999930858612},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2093999981880188},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.1988999992609024},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.19269999861717224}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.62917/26.71.1071","doi":"https://doi.org/10.62917/26.71.1071","is_oa":false,"landing_page_url":"https://doi.org/10.62917/26.71.1071","pdf_url":null,"source":{"id":"https://openalex.org/S7407089388","display_name":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Libro de comunicaciones 71 Congreso SEFH","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7167287617","https://openalex.org/W7125589039","https://openalex.org/W4413275928","https://openalex.org/W4387563494","https://openalex.org/W7166299536","https://openalex.org/W7124199837","https://openalex.org/W4390696626","https://openalex.org/W4409413285","https://openalex.org/W4409483959","https://openalex.org/W7130546740"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-07-04T00:00:00"}